Prof. Jonathan Chernoff

Jonathan Chernoff is a molecular oncologist and board-certified medical oncologist currently serving at Fox Chase Cancer Center, where he holds the Stanley P. Reimann Chair in Oncology Research. Since joining Fox Chase in 1991, he has made major contributions to the understanding of cell growth, migration, oncogenes, and tumor suppressor pathways. His laboratory focuses on signaling mechanisms that drive cancer progression and therapeutic resistance.

Chernoff has trained numerous graduate students and postdoctoral fellows and serves as an adjunct professor at the University of Pennsylvania and Drexel University School of Medicine. He is also a member of the Cancer Signaling and Epigenetics research program at Fox Chase.

Beyond academia, he has served on scientific advisory boards for several biotechnology and pharmaceutical companies, including Genentech and Novartis. Chernoff earned his undergraduate degree from Yale University and completed his MD and PhD at the Mount Sinai School of Medicine. He completed clinical training at the University of Pittsburgh and Johns Hopkins Oncology Center, followed by postdoctoral research at Harvard University.